Monday, September 14, 2026

CBOE Bearish By 17% In The Last 10 Sessions

CBOE Bearish By 17% In The Last 10 Sessions

(VIANEWS) - CBOE (VIX) has been up by 17.42% for the last 10 sessions. At 16:09 EST on Thursday, 13 June, CBOE (VIX) is $11.95.

Regarding CBOE's yearly highs and lows, it's 0.25% up from its 52-week low and 65.91% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a negative 0.91%, a negative 0.37%, and a positive 4.19%, respectively.

CBOE's highest amplitude of average volatility was 3.47% (last week), 3.97% (last month), and 4.19% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be overbought (>=80).

News about

  • According to Zacks on Tuesday, 11 June, "Apollo Global Management witnesses a strong price increase as TD Cowen lifts its S&P 500 index inclusion weightage for the latter. "
  • According to Zacks on Tuesday, 11 June, "Columbia Large Cap Enhanced Core Adv (CECFX Quick QuoteCECFX - Free Report) invests most of its assets along with borrowings, if any, in common stocks that comprise the convertible securities on the S&P 500 Index."
  • According to Zacks on Tuesday, 11 June, "The Finance sector and the Zacks S&P 500 index have gained 20.9% and 23.2% in the said time frame, respectively. "
  • According to Zacks on Tuesday, 11 June, "Stocks with rising earnings estimates have significantly outperformed the S&P 500 year after year, whereas stocks with falling earnings estimates have underperformed the S&P 500 year after year."

More news about CBOE (VIX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com